Editas Medicine to Participate in Upcoming Investor Conferences
Editas Medicine (Nasdaq: EDIT), a clinical-stage gene editing company, has announced its participation in four upcoming investor conferences in September and October 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Editas Medicine (Nasdaq: EDIT), a clinical-stage gene editing company, has announced its participation in four upcoming investor conferences in September and October 2024. The company's management will engage in fireside chat discussions about Editas and its programs, including reni-cel.
The conferences include:
- Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York
- 2024 Wells Fargo Healthcare Conference on September 5 in Boston
- 2024 Cantor Global Healthcare Conference on September 17 in New York
- Chardan 8th Annual Genetic Medicines Conference on October 1 in New York
Live webcasts of Editas Medicine's presentations will be available on the company's website, with archived replays accessible for approximately 30 days after each event.
Details
News Market Reaction – EDIT
The recorded move for EDIT in the trading session of this news was -3.66%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following upcoming investor conferences to discuss the Company and its programs, including reni-cel:
- Morgan Stanley 22nd Annual Global Healthcare Conference
Format: Fireside Chat
Date: Wednesday, September 4
Time: 4:05 p.m. ET
Location: New York, NY
- 2024 Wells Fargo Healthcare Conference
Format: Fireside Chat
Date: Thursday, September 5
Time: 4:30 p.m. ET
Location: Boston, MA
- 2024 Cantor Global Healthcare Conference
Format: Fireside Chat
Date: Tuesday, September 17
Time: 1:20 p.m. ET
Location: New York, NY
- Chardan 8th Annual Genetic Medicines Conference
Format: Fireside Chat
Date: Tuesday, October 1
Time: 4:00 p.m. ET
Location: New York, NY
To access the live webcasts of Editas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.
About Editas Medicine
As a clinical-stage gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute’s Cas12a patent estate and Broad Institute and Harvard University’s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.